Prof. Courbage and Prof. Grigolini New Co-Editors-in-Chief of Chaos, Solitons & Fractals
Amsterdam, 16 March 2010 - Elsevier, a world-leading publisher of scientific, technical, and medical information products and services, announced today that Prof. Maurice Courbage (Université Denis Diderot - Paris 7) and Prof. Paolo Grigolini (University of North Texas, USA) have been appointed as the new Co-Editors-in-Chief of Chaos, Solitons & Fractals.
Prof. Courbage works in the Theory of Complex Systems research group of the Université Denis Diderot - Paris 7. His research interests include nonlinear science and complexity, including quantum and classical statistical mechanics, neurodynamics, ergodic theory and cellular automata. Prof. Grigolini is a member of the Center for Nonlinear Science at the University of Texas where he works on quantum mechanics, statistical physics, complex networks and biological systems, in particular the complexity in neurophysiological processes.
In addition to the two new co-Editors-in-Chief, Chaos, Solitons & Fractals has refined its Aims & Scope, which now center on the interdisciplinary theme of complexity. The journal has also undergone some changes in the editorial structure. Regular articles, letters and reviews, as well as “Frontiers” papers, up-to-date overviews of a particular field, will be the main article types throughout the journal. The journal also has a new look, including the cover and will be published in two column formatting. Submissions will be accepted shortly at http://ees.elsevier.com/chaos/.
“It is our ambition to develop Chaos, Solitons & Fractals into a leading journal in the exciting field of complexity”, commented Prof. Grigolini.
Prof. Courbage added, “One of the main hallmarks of the journal will be the interdisciplinarity of complex systems. We are pleased to be joined by some excellent editorial board members, who will be instrumental in attracting leading authors in the field.”About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 215 239 3508